Find the latest information on COVID-19, monkeypox, and the flu vaccine
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Moyamoya and Its History
One the rarest forms of occlusive cerebrovascular disorders encountered in neurosurgery is moyamoya disease. Fragile blood vessels proliferate around a blocked artery in an attempt to bypass an occlusion and their appearance on a cerebral angiogram resembles a "puff of smoke" or "moyamoya," a term coined by a Japanese team who first described the disease. It can affect both children and adults usually with symptoms of transient ischemic attacks, strokes, headaches and seizures.
There is currently no drug treatment that is effective for moyamoya disease and surgery is aimed at bypassing the blockage with another artery to restore normal blood flow. Dr. Steinberg has performed more than 1,000 of these revascularization procedures for moyamoya, making his case experience with this disease one of the largest in the world.
Clinical Trials for Moyamoya
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Moyamoya CenterThe Stanford Moyamoya Center is the largest moyamoya referral center in the world. Our experienced professionals work hard to ensure our patients live full, healthy lives.
Stanford Neuroscience Health Center213 Quarry Road
Palo Alto, CA 94304
Attempting to bypass an arterial blockage in the brain, many small blood vessels surround the blockage, trying to reestablish blood flow. This is moyamoya disease.
Moyamoya moyamoya disease moyamoya syndrome